Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Other Accumulated Expenses: 2018-2025

Historic Other Accumulated Expenses for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Mar 2025 value amounting to $674,391.

  • China SXT Pharmaceuticals' Other Accumulated Expenses rose 86.53% to $674,391 in Q1 2025 from the same period last year, while for Mar 2025 it was $674,391, marking a year-over-year increase of 86.53%. This contributed to the annual value of $674,391 for FY2025, which is 86.53% up from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Other Accumulated Expenses of $674,391 as of FY2025, which was up 86.53% from $361,543 recorded in FY2024.
  • In the past 5 years, China SXT Pharmaceuticals' Other Accumulated Expenses registered a high of $1.2 million during FY2022, and its lowest value of $361,543 during FY2024.
  • For the 3-year period, China SXT Pharmaceuticals' Other Accumulated Expenses averaged around $608,389, with its median value being $674,391 (2025).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first spiked by 184.90% in 2021, then tumbled by 54.19% in 2024.
  • China SXT Pharmaceuticals' Other Accumulated Expenses (Yearly) stood at $819,677 in 2021, then spiked by 41.80% to $1.2 million in 2022, then slumped by 32.10% to $789,232 in 2023, then tumbled by 54.19% to $361,543 in 2024, then skyrocketed by 86.53% to $674,391 in 2025.